Résumé
Nous avons cherché à vérifier si l’atténuation du stress oxydatif lié au diabète pourrait diminuer le processus de la mort des cellules cardiaques. Notre étude a montré que l’apoptose cardiaque est semblable à une des réponses cellulaires majeures au diabète: induite par un stress oxydatif. La Glisodin®, une association de SOD de melon et de protéine de blé, également un puissant antioxydant, a freiné le développement de la cardiomyopathie diabétique. Nos résultats montrent une réduction significative des TUNEL-positifs dans les cardiomyocytes, observée chez le groupe diabétique traité par la Glisodin®. On a observé une diminution significative de la teneur en glutathion réduit, de l’activité de la SOD et de la catalase dans le cœur de rats diabétiques accompagnée par une augmentation des concentrations plasmatiques des LPO en comparaison aux rats traités par Glisodin®. Le traitement des rats diabétiques par la Glisodin® a rétabli l’augmentation de l’activité de la LDH et de la CPK exprimée chez les rats non traités. En conclusion, nos résultats suggèrent que l’atténuation de l’apoptose des cellules cardiaques par la Glisodin® assoie son effet préventif contre le développement de la cardiomyopathie diabétique. Toutefois, cet effet est principalement médié par une action antioxydante suppressive du stress oxydatif plutôt que par une action hypoglycémiante.
Abstract
We aimed to test whether attenuation of cardiac cell death can prevent diabetic cardiomyopathy. Our study showed that cardiac apoptosis as a major cellular response to diabetes is induced by hyperglycemia-derived oxidative stress. Glisodin® as a potent antioxidant prevents the development of diabetic cardiomyopathy. Eight weeks after STZ treatment, cardiac apoptosis was examined by terminal deoxynucleotidyl transferase-mediated dUTP labeling (TUNEL) assay. Oxidative stress in the heart tissue was evaluated by measuring GSH content, LPO level, and catalase and SOD activities. Cardiomyopathy was evaluated by measuring LDH and CPK activities. Our results show a significant reduction in diabetesinduced increases in TUNEL-positive cells was observed in a Glisodin® treatment group. A significant decrease of reduced glutathione content, superoxide dismutase, and catalase activities in the heart of diabetic rats accompanied by increased LPO plasma levels, but not in Glisodin®-treated rats, was observed. LDH and CPK activities as biomarkers of cardiomyopathy were decreased in Glisodin®-treated diabetic rats compared to diabetic-controlled rats. In conclusion, our results suggest that attenuation of cardiac cell death by Glisodin® treatment results in a significant prevention of the development of diabetic cardiomyopathy. This process is mediated by the antioxidant effect of Glisodin® to suppress oxidative stress in the heart.
Références
Aebi H (1983) Catalase. In: Methods in enzymatic analysis (Ed. Bergmer HU), Vol. 3 Academic press, New York, pp. 276–286
Aliciguzel Y, Ozen I, Aslan M, Karayalcin U (2003) Activities of xanthine oxidoreductase ant antioxidant enzymes in different tissues of diabetic rats. J Lab Clin Med 142(3): 172–176
An D, Rodrigues B (2006) Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol-Heart Circ Physiol 291: 1489–1506
Artwohl M, Roden M, Waldhausl W, et al. (2004) Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J 18:146–148
Awaji Y, Hashimoto H, Matsui Y, et al. (1990) Isoenzyme profiles of creatine kinase, lactate dehydrogenase and aspartate aminotransferase in the diabetic heart: comparison with hereditary and catecholamine cardiomyopathies. Cardiovasc Res 24: 547–554
Baumgartner-Parzer SM, Wagner L, Pettermann M, et al. (1995) Highglucose-triggered apoptosis in cultured endothelial cells. Diabetes 44: 1323–1327
Beauchamps C, Fridovich L (1971) Superoxide dismutase: improved assays and assay applicable to acrylamide gels. Anal Biochem 44: 276–287
Berry C, Hamilton CA, Brosnan MJ, et al. (2000) Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101: 2206–2212
Bonnefont-Rousselot D (2002) Glucose and reactive oxygen species. Current Opinion in Clinical Nutrition Metabolic Care 5: 561–568
Bowie A, O’Neill LAJ (2000) Oxidative stress and nuclear factor kB activation. Biochem Pharmacol 59: 7–11
Christopher CL, Mathuram LN, Genitta G, et al. (2003) Omega-3 polyunsaturated fatty acids inhibit the accumulation of PAS — positive material in the myocardium of STZ-diabetic wistar rats. Int J Cardiol 88: 183–190
Clemente MG, De Virgiliis S, Kang JS, et al. (2003) Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52: 218–223
Chu N, Speigelman D, Hotamilsgil GS, et al. (2001) Plasma insulin, leptin and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 157: 495–503
Cnop M, Hannaert JC, Hoorens A, et al. (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50: 1771–1777
Dandona P, Thusu K, Cook S, et al. (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444–445
Das S, Vasisht S, Snehalata M, et al. (2000) Correlation between total antioxidant status and lipid peroxidation in hypercholesterolemia. Curr Sci 78: 486
Ezpeleta I, Arangoa MA, Irache JM, et al. (1999) Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus. Int J Pharm 191: 25–32
Fasano A, Not T, Wang W, et al. (2000) Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355: 1518–1519
Fiordaliso F, De Angelis N, Bai A, et al. (2007) Effect of beta-adrenergic and renin-angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats. Life Sci 81: 951–959
Fiordaliso F, Bianchi R, Staszewsky L, et al. (2004). Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37: 959–968
Fiordaliso F, Li B, Latini R, et al. (2000). Myocyte death in streptozotocin-induced diabetes in rats in angiotensinII dependent. Lab Invest 80: 513–527
Frustaci A, Kajstura, J, Chimenti C, et al. (2000) Myocardial cell death in human diabetes. Circ Res 87: 1123–1132
Grundy SM, Benjamin IJ, Burke GL, et al. (1999). Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 100: 1134–1146
Joanny Menvielle-Bourg F (2005) La superoxyde dismutase, puissant antioxydant naturel, désormais disponible par voie orale. Phytothérapie 3: 118–121
Kajstura J, Fiordaliso F, Andreoli AM, et al. (2001) IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50: 1414–1424
Kang YJ (2001) Molecular and cellular mechanisms of cardiotoxicity. Environ Health Perspect 109(Suppl 1): 27–34
Li N, Karin M (1999) Is NF-kB the sensor of oxidative stress? FASEB J 13: 1137–1143
Li S, Li X, Rozanski GJ (2003) Regulation of glutathione in cardiac myocytes. J Mol Cell Cardiol 35: 1145–1152
Mauguet MC, Legrand J, Brujes L, et al. (2002) Gliadin matrices for microencapsulation processes by simple coacervation method. J Microencapsul 19: 377–384
Montilla PL, Vargas JF, Tunez IF, et al. (1998) Oxidative stress in diabetic rats induced by streptozotocin: preventive effects of melatonin. J Pineal Res 25: 94–100
Oberley LW, Spitz DR (1985) Assay of peroxide dismutase using nitroblue tetrazolium. In: Greenwald RA (ed) Handbook of methods for oxygen radical research. CRC Press, Boca Raton, pp. 217–220
Ohkawa H, Oshishi N, Yagi K (1979) Assay for lipid peroxydation in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351–358
Ouali K, Trea F, Toumi L, et al. (2007) L’hespéridine, un antioxydant flavonoïde qui diminue le stress oxydatif et prévient les malformations foetales au cours du diabète gestationnel expérimental. Phytothérapie 5: 204–209
Paolisso G, Tataranni PA, Foley JE, et al. (1995) A high concentration of fasting plasma non-esterified is fatty acids a risk factor for the development of NIDDM. Diabetologia 38: 1213–1217
Pon Velayutham A, Kuruvimalai Ekambaram S, Periasamy S, Chennam Srinivasulu S (2007) Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats. Pharmacol Res 55: 433–440
Renard D, Robert P, Lavenant L, et al. (2002) Biopolymeric colloidal carriers for encapsulation or controlled release applications. Int J Pharm 242: 163–166
Rodrigues B, Cam MC, Jian K, et al. (1997) Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes 46(8): 1346–1353
Rodrigues B, Cam MC, McNeill JH (1995) Myocardial substrate metabolism: Implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169–179
Schreck R, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-kB transcription factor and HIV-1. Trend Cell Biol 1: 32–42
Shizukuda Y, Reyland ME, Buttrick PM (2002) Protein kinase C delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am J Physiol Heart Circ Physiol 282: 1625–1634
Srinivasan S, Stevens M, Wiley JW (2000) Diabetic peripheral neuropathy: Evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49: 1932–1938
Swynghedauw B (1999) Molecular mechanisms of myocardial remodelling Physiol Rev 79: 215–262
Tanaka Y, Gleason CE, Tran PO, et al. (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci 96: 10857–10862
Vouldoukis I, Lacan D, Kamate C, et al. (2004) Antioxidant and antiinflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity. J Ethnopharmacol 94: 67–75
Vouldoukis I, Conti M, Krauss P, et al. (2004) Supplementation with gliadin-combined plant superoxide dismutase extract promotes antioxidant defences and protects against oxidative stress. Phytother Res 18: 957–962
Wang W, Uzzau S, Goldblum SE, Fasano A (2000) Human zonulin, a potential modulator of intestinal tight junctions J Cell Sci 113(Pt 24): 4435–4440
Weckbecker G, Cory JG (1988) Ribonucleotide reductase activity and growth of glutathione depleted mouse leukaemia LI210 cells in vitro. Cancer Let 40: 257–264
Wolff SP, Dean RT (1987) Glucose autooxidation and protein modification. Biochem J 245: 243–250
Wu TG, Li W, Lin Z, Wang Le (2008) Effects of folic acid on cardiac myocyte apoptosis in rats with streptozotocin-induced diabetes mellitus. Cardiovasc Drugs Ther 22: 299–304
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Trea, F., Ouali, K., Baba-Ahmed, F. et al. La Glisodin®, un extrait de melon, atténue l’apoptose des cardiomyocytes via la suppression du stress oxydant cardiaque au cours du diabète chronique expérimental. Phytothérapie 11, 339–347 (2013). https://doi.org/10.1007/s10298-013-0818-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10298-013-0818-2